The role of Mastermind in B-cell lymphoma
The role of Mastermind in B-cell lymphoma
批准号:
23590413
负责人:
HIGASHI Morihiro
金额:
$3.33万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
中文摘要
Mastermind (Mam)是Notch信号的关键调节剂,在b细胞从GC向MZ的分化过程中起着重要作用。我们发现1)MamL1和MamL3在反应性淋巴结的GC和MZ中表达。2) Mam在50%的MC亚型霍奇金淋巴瘤中表达,而在NS亚型中表达较低。3)滤泡性淋巴瘤表达Mam,边缘区淋巴瘤表达Mam较低。4)淋巴瘤细胞系中Hes-1的表达与Notch1或Jag2的表达相关,表明Notch通路在淋巴瘤细胞系中被细胞自主激活。5) he -1表达与LR11表达相关。LR11可能在Notch激活的同时被激活。为了阐明GC源性b细胞淋巴瘤的生物学和病理学差异,需要进一步研究Notch相关分子的表达和Notch激活状态。
英文摘要
Mastermind (Mam) is a pivotal modulator of Notch signaling and has essential roles in the differentiation of B-cells from GC to MZ. We showed that 1) MamL1 and MamL3 were expressed in the GC and MZ of reactive lymph node. 2) Mam was expressed in 50% of cases with MC subtype of the Hodgkin lymphoma, whereas the expression was low in the cases with NS subtype. 3) Mam was expressed in the cases with follicular lymphoma and was low in the cases with marginal zone lymphoma. 4) The expression of Hes-1 was correlated with the expression of Notch1 or Jag2 in lymphoma cell lines, suggesting the Notch pathway is activated by cell-autonomously within lymphoma cell lines. 5) The expression of Hes-1 was correlated with LR11 expression. LR11 may be activated in parallel with Notch activation. Further investigation of the expression of Notch related molecules and the status of Notch activation is needed to clarify the biological and pathological differences in B-cell lymphomas originated from the GC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
G-CSF induces the release of the soluble form of LR11, a regulator of myeloid cell mobilization in bone marrow
G-CSF 诱导可溶形式 LR11 的释放,LR11 是骨髓中骨髓细胞动员的调节剂
DOI:
10.1007/s00277-014-2033-0
发表时间:
2014
期刊:
Ann Hematol
影响因子:
3.5
作者:
[Shimizu N, Nakaseko C, Jiang M, Nishii K, Yokote K, Iseki T, Higashi M, Tamaru J, Schneider WJ, Bujo H]
通讯作者:
Bujo H
DOI:
10.1158/1078-0432.ccr-11-2395
发表时间:
2012-04-15
期刊:
CLINICAL CANCER RESEARCH
影响因子:
11.5
作者:
[Kanemitsu, Naoko, Isobe, Yasushi, Komatsu, Norio]
通讯作者:
Komatsu, Norio
悪性リンパ腫におけるLR11発現と意義
LR11在恶性淋巴瘤中的表达及意义
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[東守洋, 得平道英, 川口岳晴, 竹内正博, 大和田千佳子, 中世古知明, 武成英明, 木崎昌弘, 田丸淳一]
通讯作者:
田丸淳一
Expression of LR11 in malignant lymphoma
LR11在恶性淋巴瘤中的表达
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[東守洋, 得平道英, 川口岳晴, 竹内正博, 大和田千佳子, 中世古知明, 武成英明, 木崎昌弘, 田丸淳一]
通讯作者:
田丸淳一
【分子病態からみた血液疾患診療の進歩】ホジキンリンパ腫の病態解析の新展開
【分子病理学视角下血液病治疗进展】霍奇金淋巴瘤病理分析新进展
DOI:
--
发表时间:
2011
期刊:
血液内科
影响因子:
--
作者:
[Yamaguchi H, Kuboki Y, Hatori T, Yamamoto M, Shiratori K, Kawamura S, Kobayashi M, Shimizu M, Ban S, Koyama I, Higashi M, et. al, 東守洋,田丸淳一]
通讯作者:
東守洋,田丸淳一
共 13 条
海外基金